Search filters

List of works by Heidi A Neubauer

An oncogenic role for sphingosine kinase 2.

scientific article published on 30 August 2016

CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.

scientific article published on 20 July 2017

Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival

scientific article published on 27 February 2019

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma

scientific article published in 2019

Direct Targeting Options for STAT3 and STAT5 in Cancer

scientific article published on 03 December 2019

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

scientific article published on 17 November 2017

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer

article

NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth

scientific article published on 17 April 2018

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

scientific article published on 18 January 2020

Roles, regulation and inhibitors of sphingosine kinase 2.

scientific article published on 07 June 2013

STAT3 and STAT5 Activation in Solid Cancers

scientific article published on 25 September 2019

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

scientific article published on 21 April 2020

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations

scientific article published on 08 November 2019

Structural and functional consequences of the STAT5BN642H driver mutation.

scientific article published on 7 June 2019

Tumor target amplification: implications for nano drug delivery systems

scientific article published on 15 February 2018

Validation of commercially available sphingosine kinase 2 antibodies for use in immunoblotting, immunoprecipitation and immunofluorescence

scientific article published on 6 December 2016